Asset Management
Compare Stocks
5 / 10Stock Comparison
MGLD vs CODI vs ITRI vs KINS vs HCSG
Revenue, margins, valuation, and 5-year total return — side by side.
Conglomerates
Hardware, Equipment & Parts
Insurance - Property & Casualty
Medical - Care Facilities
MGLD vs CODI vs ITRI vs KINS vs HCSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Conglomerates | Hardware, Equipment & Parts | Insurance - Property & Casualty | Medical - Care Facilities |
| Market Cap | $48M | $905M | $3.60B | $234M | $1.60B |
| Revenue (TTM) | $30M | $1.85B | $2.35B | $199M | $1.84B |
| Net Income (TTM) | $-3M | $-227M | $289M | $41M | $59M |
| Gross Margin | 72.5% | 38.7% | 38.6% | 57.7% | 13.3% |
| Operating Margin | -22.2% | 0.3% | 13.2% | 25.6% | 3.0% |
| Forward P/E | — | 150.4x | 13.5x | 7.0x | 20.8x |
| Total Debt | $2M | $1.88B | $1.29B | $4M | $25M |
| Cash & Equiv. | $5M | $68M | $1.02B | $12M | $161M |
MGLD vs CODI vs ITRI vs KINS vs HCSG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 22 | May 26 | Return |
|---|---|---|---|
| The Marygold Compan… (MGLD) | 100 | 60.5 | -39.5% |
| Compass Diversified (CODI) | 100 | 50.6 | -49.4% |
| Itron, Inc. (ITRI) | 100 | 154.0 | +54.0% |
| Kingstone Companies… (KINS) | 100 | 303.8 | +203.8% |
| Healthcare Services… (HCSG) | 100 | 120.1 | +20.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MGLD vs CODI vs ITRI vs KINS vs HCSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MGLD lags the leaders in this set but could rank higher in a more targeted comparison.
CODI is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 1.09, yield 4.2%
- Beta 1.09, yield 4.2%, current ratio 2.42x
- 4.2% yield, vs KINS's 0.6%, (3 stocks pay no dividend)
Among these 5 stocks, ITRI doesn't own a clear edge in any measured category.
KINS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 28.4%, EPS growth 94.6%, 3Y rev CAGR 15.2%
- 101.9% 10Y total return vs ITRI's 94.4%
- Lower volatility, beta 0.28, Low D/E 3.6%, current ratio 1.22x
- 28.4% revenue growth vs MGLD's -8.2%
HCSG ranks third and is worth considering specifically for momentum.
- +55.8% vs CODI's -30.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 28.4% revenue growth vs MGLD's -8.2% | |
| Value | Lower P/E (7.0x vs 20.8x) | |
| Quality / Margins | 20.5% margin vs MGLD's -19.3% | |
| Stability / Safety | Beta 0.28 vs ITRI's 1.53, lower leverage | |
| Dividends | 4.2% yield, vs KINS's 0.6%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +55.8% vs CODI's -30.3% | |
| Efficiency (ROA) | 9.8% ROA vs MGLD's -11.4%, ROIC 46.6% vs -18.8% |
MGLD vs CODI vs ITRI vs KINS vs HCSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MGLD vs CODI vs ITRI vs KINS vs HCSG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KINS leads in 4 of 6 categories
MGLD leads 0 • CODI leads 0 • ITRI leads 0 • HCSG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
KINS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ITRI is the larger business by revenue, generating $2.3B annually — 77.8x MGLD's $30M. KINS is the more profitable business, keeping 20.5% of every revenue dollar as net income compared to MGLD's -19.3%. On growth, HCSG holds the edge at +6.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $30M | $1.8B | $2.3B | $199M | $1.8B |
| EBITDAEarnings before interest/tax | -$4M | $109M | $367M | $54M | $72M |
| Net IncomeAfter-tax profit | -$3M | -$227M | $289M | $41M | $59M |
| Free Cash FlowCash after capex | -$2M | $10M | $393M | $73M | $139M |
| Gross MarginGross profit ÷ Revenue | +72.5% | +38.7% | +38.6% | +57.7% | +13.3% |
| Operating MarginEBIT ÷ Revenue | -22.2% | +0.3% | +13.2% | +25.6% | +3.0% |
| Net MarginNet income ÷ Revenue | -19.3% | -12.3% | +12.3% | +20.5% | +3.2% |
| FCF MarginFCF ÷ Revenue | -11.2% | +0.5% | +16.7% | +36.7% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -5.9% | -3.3% | -3.2% | +6.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +68.7% | -5.1% | -16.9% | +157.5% | +175.0% |
Valuation Metrics
KINS leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 5.6x trailing earnings, KINS trades at a 80% valuation discount to HCSG's 27.5x P/E. On an enterprise value basis, KINS's 4.2x EV/EBITDA is more attractive than HCSG's 22.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $48M | $905M | $3.6B | $234M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $46M | $2.7B | $3.9B | $226M | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | -8.04x | -3.94x | 12.46x | 5.61x | 27.54x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 150.38x | 13.47x | 7.03x | 20.83x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.06x | — |
| EV / EBITDAEnterprise value multiple | — | 14.99x | 10.48x | 4.22x | 22.38x |
| Price / SalesMarket cap ÷ Revenue | 1.60x | 0.48x | 1.52x | 1.17x | 0.87x |
| Price / BookPrice ÷ Book value/share | 2.04x | 1.58x | 2.15x | 1.86x | 3.19x |
| Price / FCFMarket cap ÷ FCF | — | — | 9.44x | 3.20x | 11.49x |
Profitability & Efficiency
KINS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
KINS delivers a 40.0% return on equity — every $100 of shareholder capital generates $40 in annual profit, vs $-50 for CODI. KINS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to CODI's 3.27x. On the Piotroski fundamental quality scale (0–9), ITRI scores 7/9 vs MGLD's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -14.7% | -49.6% | +17.2% | +40.0% | +11.8% |
| ROA (TTM)Return on assets | -11.4% | -7.3% | +7.7% | +9.8% | +7.3% |
| ROICReturn on invested capital | -18.8% | +1.0% | +13.1% | +46.6% | +9.0% |
| ROCEReturn on capital employed | -26.0% | +2.4% | +11.4% | +20.3% | +7.7% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 5 | 7 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.10x | 3.27x | 0.74x | 0.04x | 0.05x |
| Net DebtTotal debt minus cash | -$3M | $1.8B | $267M | -$8M | -$136M |
| Cash & Equiv.Liquid assets | $5M | $68M | $1.0B | $12M | $161M |
| Total DebtShort + long-term debt | $2M | $1.9B | $1.3B | $4M | $25M |
| Interest CoverageEBIT ÷ Interest expense | -3.90x | -0.97x | 14.38x | 115.65x | 33.02x |
Total Returns (Dividends Reinvested)
KINS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in KINS five years ago would be worth $19,940 today (with dividends reinvested), compared to $3,319 for MGLD. Over the past 12 months, HCSG leads with a +55.8% total return vs CODI's -30.3%. The 3-year compound annual growth rate (CAGR) favors KINS at 127.2% vs MGLD's -11.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +27.4% | +158.7% | -14.1% | -0.3% | +28.6% |
| 1-Year ReturnPast 12 months | +32.7% | -30.3% | -23.7% | -10.1% | +55.8% |
| 3-Year ReturnCumulative with dividends | -31.4% | -25.6% | +20.8% | +1073.4% | +48.6% |
| 5-Year ReturnCumulative with dividends | -66.8% | -35.5% | -7.2% | +99.4% | -21.1% |
| 10-Year ReturnCumulative with dividends | -66.8% | +53.7% | +94.4% | +101.9% | -26.8% |
| CAGR (3Y)Annualised 3-year return | -11.8% | -9.4% | +6.5% | +127.2% | +14.1% |
Risk & Volatility
Evenly matched — MGLD and HCSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
MGLD is the less volatile stock with a -0.02 beta — it tends to amplify market swings less than ITRI's 1.53 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 91.5% from its 52-week high vs ITRI's 57.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.02x | 1.09x | 1.53x | 0.28x | 1.12x |
| 52-Week HighHighest price in past year | $1.38 | $17.46 | $142.00 | $22.40 | $24.39 |
| 52-Week LowLowest price in past year | $0.64 | $4.58 | $78.53 | $13.08 | $12.66 |
| % of 52W HighCurrent price vs 52-week peak | +81.5% | +68.9% | +57.1% | +72.1% | +91.5% |
| RSI (14)Momentum oscillator 0–100 | 51.5 | 70.0 | 35.2 | 50.5 | 61.8 |
| Avg Volume (50D)Average daily shares traded | 17K | 1.2M | 893K | 113K | 676K |
Analyst Outlook
Evenly matched — CODI and HCSG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CODI as "Hold", ITRI as "Hold", KINS as "Buy", HCSG as "Hold". Consensus price targets imply 68.8% upside for ITRI (target: $137) vs 9.8% for HCSG (target: $25). For income investors, CODI offers the higher dividend yield at 4.16% vs KINS's 0.62%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $15.00 | $137.00 | — | $24.50 |
| # AnalystsCovering analysts | — | 14 | 37 | 4 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | +4.2% | — | +0.6% | — |
| Dividend StreakConsecutive years of raises | — | 0 | 1 | 0 | 20 |
| Dividend / ShareAnnual DPS | — | $0.50 | — | $0.10 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.0% | +2.8% | 0.0% | +3.9% |
KINS leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.
MGLD vs CODI vs ITRI vs KINS vs HCSG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MGLD or CODI or ITRI or KINS or HCSG a better buy right now?
For growth investors, Kingstone Companies, Inc.
(KINS) is the stronger pick with 28. 4% revenue growth year-over-year, versus -8. 2% for The Marygold Companies, Inc. (MGLD). Kingstone Companies, Inc. (KINS) offers the better valuation at 5. 6x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Kingstone Companies, Inc. (KINS) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MGLD or CODI or ITRI or KINS or HCSG?
On trailing P/E, Kingstone Companies, Inc.
(KINS) is the cheapest at 5. 6x versus Healthcare Services Group, Inc. at 27. 5x. On forward P/E, Kingstone Companies, Inc. is actually cheaper at 7. 0x.
03Which is the better long-term investment — MGLD or CODI or ITRI or KINS or HCSG?
Over the past 5 years, Kingstone Companies, Inc.
(KINS) delivered a total return of +99. 4%, compared to -66. 8% for The Marygold Companies, Inc. (MGLD). Over 10 years, the gap is even starker: KINS returned +101. 9% versus MGLD's -66. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MGLD or CODI or ITRI or KINS or HCSG?
By beta (market sensitivity over 5 years), The Marygold Companies, Inc.
(MGLD) is the lower-risk stock at -0. 02β versus Itron, Inc. 's 1. 53β — meaning ITRI is approximately -8773% more volatile than MGLD relative to the S&P 500. On balance sheet safety, Kingstone Companies, Inc. (KINS) carries a lower debt/equity ratio of 4% versus 3% for Compass Diversified — giving it more financial flexibility in a downturn.
05Which is growing faster — MGLD or CODI or ITRI or KINS or HCSG?
By revenue growth (latest reported year), Kingstone Companies, Inc.
(KINS) is pulling ahead at 28. 4% versus -8. 2% for The Marygold Companies, Inc. (MGLD). On earnings-per-share growth, the picture is similar: Kingstone Companies, Inc. grew EPS 94. 6% year-over-year, compared to -1426. 1% for Compass Diversified. Over a 3-year CAGR, KINS leads at 15. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MGLD or CODI or ITRI or KINS or HCSG?
Kingstone Companies, Inc.
(KINS) is the more profitable company, earning 20. 5% net margin versus -19. 3% for The Marygold Companies, Inc. — meaning it keeps 20. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KINS leads at 25. 6% versus -22. 2% for MGLD. At the gross margin level — before operating expenses — MGLD leads at 72. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MGLD or CODI or ITRI or KINS or HCSG more undervalued right now?
On forward earnings alone, Kingstone Companies, Inc.
(KINS) trades at 7. 0x forward P/E versus 150. 4x for Compass Diversified — 143. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ITRI: 68. 8% to $137. 00.
08Which pays a better dividend — MGLD or CODI or ITRI or KINS or HCSG?
In this comparison, CODI (4.
2% yield), KINS (0. 6% yield) pay a dividend. MGLD, ITRI, HCSG do not pay a meaningful dividend and should not be held primarily for income.
09Is MGLD or CODI or ITRI or KINS or HCSG better for a retirement portfolio?
For long-horizon retirement investors, Kingstone Companies, Inc.
(KINS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 28), 0. 6% yield, +101. 9% 10Y return). Itron, Inc. (ITRI) carries a higher beta of 1. 53 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KINS: +101. 9%, ITRI: +94. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MGLD and CODI and ITRI and KINS and HCSG?
These companies operate in different sectors (MGLD (Financial Services) and CODI (Industrials) and ITRI (Technology) and KINS (Financial Services) and HCSG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MGLD is a small-cap quality compounder stock; CODI is a small-cap income-oriented stock; ITRI is a small-cap deep-value stock; KINS is a small-cap high-growth stock; HCSG is a small-cap quality compounder stock. CODI, KINS pay a dividend while MGLD, ITRI, HCSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.